Experience report: World Stroke Day
DOI:
https://doi.org/10.34019/1982-8047.2019.v45.25663Keywords:
Stroke, Neurology, Public HealthAbstract
Introduction: Stroke is one of the most prevalent causes of death and acquired inability all over the world. Besides the high rates of mortality, stroke is an important cause of neurologic deficits that will need rehabilitee, since 70% of the patients will not come back for their work and 30% will need help to walk. Understand the epidemiology profile and the contribution of any risk factor is essential to establish specific local politics in order to lower the incidence and complication rates, not only in short term but also in long term. Prevention can be made at 90% cases of stroke, since these cases are attributed to modifiable risk factors. Objective: Guide and alert Juiz de Fora’s population about changeable risk factors and prevention of stroke. Experience report: During the final week of October we made educative speeches and offer some guidance about stroke and his modifiable risk factors. Furthermore, the neurology patients, their companions and local people, had their blood pressure assessed, as so as their abdominal circumference. Those with some alteration were guided to look for specific medical support. Conclusion: Education about cardiovascular diseases prevention, in special stroke, which is known for having so many modifiable risk factors, is essential to avoid the incidence of these pathology to increase.
Downloads
References
Chen R, Obviagele B, Feng W. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci. 2016; 351(4):380-386.
Guzik A, Bushnell C. Stroke epidemiology and risk factor management. CONTINUUM: Lifelong Learning Neurol. 2017; 23(1):15-39.
Goulart AC. Epidemiologia do Acidente Vascular Cerebral no Brasil: experiência do Estudo de Mortalidade e Morbidade do AVC. 2017.
Benjamim EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carsol AP, et al. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association. 2019; 139(10):281-327.
Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 2016; 15(9):913-924
De Carvalho PC, Dos Santos LAD, Silva SM, Cavalli SS, Corrêa JCF. Avaliação da qualidade de vida antes e após terapia com dança sênior em pacientes hemiparéticos pós-AVE. ConScientia e Saúde. 2012;11:573-9.
Franchignoni F, Salaffi F. Quality of life assessment in rehabilitation medicine. Eur Med Phys. 2003; 39:191-8.
Fontes N. A doença vascular cerebral estabelecida - recuperação motora. Geriatria. 1998; 11(104):5-10.
Han B, Haley WE. Family Caregiving for Patients With Stroke - Review ad Analyses. Stroke. 1999; 30:1478-85.
O'Donnell MJ. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. The Lancet. 2016;388(10046):761-75.
Bridgwood B, Lager KE, Mistri AK, Khunti K, Wilson AD, Modi P. Interventions for improving modifiable risk factor control in the secondary prevention of stroke. Cochrane Database Syst Rev. 2018; 5. Art. No.: CD009103. DOI: 10.1002/14651858.CD009103.pub3.
Arboix A. Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J Clin Cases. 2015; 3(5):418-8.
Hussain MA, Al Mamun A, Peters SA, Woodward M, Huxley RR. The burden of cardiovascular disease attributable to major modifiable risk factors in Indonesia. J Epidemiol. 2016;26(10):515-21.
Truthmann J, Busch MA, Scheidt-Nave C, Mensink GBM, Gößwald A, Endres M, et al. Modifiable cardiovascular risk factors in adults aged 40–79 years in Germany with and without prior coronary heart disease or stroke. BMC public health. 2015; 15(1):701-1.
Sandhu RK, Dolovich L, Deif B, Barake W, Agarwal G, Grinvalds A et al. High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme. Open Heart. 2016; 3(2): e000515.
Lakka HM, Laaksonen DE, Lakka TA, Niskanem LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288(21):2709-16.
Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diab Care. 2003; 26(3):575-81.
Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation. 2003; 108(13):1541-45.
Gang H, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K for the DECODE Study Group. Prevalence of the metabolic syndrome and its relation to allcause and cardiovascular mortality in nondiabetic European men in women. Arch Intern Med. 2004; 164(10):1066-76.
Girman CJ, Rhodes T, Mercuri M, Pyörälä K, Kjekshus J, Pedersen TR et al. for the 4S Group and the AFCAPS/TexCAPS Research Group. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/ TexCAPS). Am J Cardiol. 2004; 93(2):136-41.
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Cholesterol. JAMA. 2001; 285(19):2486-97.
International Diabetes Federation. IDF Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.
Sanz J, Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol. 2013; 62(13):1131-43.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report):555-76.
Scala LC, Magalhães LB, Machado A. Epidemiologia da hipertensão arterial sistêmica. In: Moreira SM, Paola AV; Sociedade Brasileira de Cardiologia. Livro Texto da Sociedade Brasileira de Cardiologia. 2ª. ed. São Pauilo: Manole; 2015. p. 780-5.
Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007; 370(9603):1929-38.
Vigitel Brasil 2014. Vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. [Internet]. [Citado em 2016 Maio 10]. Disponível em: http://portalsaude.saude.gov.br/images/ pdf/2015/abril/15/PPT-Vigitel-2014-.pdf.
Gregg EW, Sattar N, Ali MK. The changing face of diabetes complications. Lancet Diabetes Endocrinol. 2016; 4(6):537-47.
Downloads
Published
How to Cite
Issue
Section
License
Cessão de Primeira Publicação à HU Revista
Os autores mantém todos os direitos autorais sobre a publicação, sem restrições, e concedem à HU Revista o direito de primeira publicação, com o trabalho licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento irrestrito do trabalho, com reconhecimento da autoria e crédito pela citação de publicação inicial nesta revista, referenciando inclusive seu DOI.
